Search by Drug Name or NDC

    NDC 00023-8335-03 TAZORAC 0.5 mg/g Details

    TAZORAC 0.5 mg/g

    TAZORAC is a CUTANEOUS GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is TAZAROTENE.

    Product Information

    NDC 00023-8335
    Product ID 0023-8335_17efca2f-f818-43c0-bdac-8047c5fa4989
    Associated GPIs 90250070004020
    GCN Sequence Number 031600
    GCN Sequence Number Description tazarotene GEL (GRAM) 0.05 % TOPICAL
    HIC3 L5F
    HIC3 Description ANTIPSORIATICS AGENTS
    GCN 29221
    HICL Sequence Number 013315
    HICL Sequence Number Description TAZAROTENE
    Brand/Generic Brand
    Proprietary Name TAZORAC
    Proprietary Name Suffix n/a
    Non-Proprietary Name tazarotene
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route CUTANEOUS
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name TAZAROTENE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020600
    Listing Certified Through 2024-12-31

    Package

    NDC 00023-8335-03 (00023833503)

    NDC Package Code 0023-8335-03
    Billing NDC 00023833503
    Package 1 TUBE in 1 CARTON (0023-8335-03) / 30 g in 1 TUBE
    Marketing Start Date 1997-08-01
    NDC Exclude Flag N
    Pricing Information N/A